This company has been marked as potentially delisted and may not be actively trading. LightWave Acquisition (LWAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LWAC vs. CALT, ZYME, SBTX, MBX, AVTE, NLTX, CYBN, BIOA, VIRI, and WHWKShould you be buying LightWave Acquisition stock or one of its competitors? The main competitors of LightWave Acquisition include Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Silverback Therapeutics (SBTX), MBX Biosciences (MBX), Aerovate Therapeutics (AVTE), Neoleukin Therapeutics (NLTX), Cybin (CYBN), BioAge Labs (BIOA), Virios Therapeutics (VIRI), and Whitehawk Therapeutics (WHWK). LightWave Acquisition vs. Its Competitors Calliditas Therapeutics AB (publ) Zymeworks Silverback Therapeutics MBX Biosciences Aerovate Therapeutics Neoleukin Therapeutics Cybin BioAge Labs Virios Therapeutics Whitehawk Therapeutics Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment. Does the media prefer CALT or LWAC? In the previous week, Calliditas Therapeutics AB (publ)'s average media sentiment score of 0.00 equaled LightWave Acquisition'saverage media sentiment score. Company Overall Sentiment Calliditas Therapeutics AB (publ) Neutral LightWave Acquisition Neutral Which has better valuation and earnings, CALT or LWAC? LightWave Acquisition has lower revenue, but higher earnings than Calliditas Therapeutics AB (publ). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62LightWave AcquisitionN/AN/AN/AN/AN/A Is CALT or LWAC more profitable? LightWave Acquisition has a net margin of 0.00% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. LightWave Acquisition's return on equity of 0.00% beat Calliditas Therapeutics AB (publ)'s return on equity.Company Net Margins Return on Equity Return on Assets Calliditas Therapeutics AB (publ)-30.18% -212.04% -27.96% LightWave Acquisition N/A N/A N/A Do insiders and institutionals have more ownership in CALT or LWAC? 2.8% of Calliditas Therapeutics AB (publ) shares are held by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryCalliditas Therapeutics AB (publ) and LightWave Acquisition tied by winning 3 of the 6 factors compared between the two stocks. Get LightWave Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LWAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LWAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LWAC vs. The Competition Export to ExcelMetricLightWave AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$215.17M$827.18M$2.09B$9.75BDividend YieldN/A4.84%13.77%4.09%P/E RatioN/A1.1312.2825.96Price / SalesN/A25.942,737,138.77120.82Price / CashN/A19.5657.5358.38Price / BookN/A6.633.066.37Net IncomeN/A-$4.90M-$456.46M$265.56M LightWave Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LWACLightWave AcquisitionN/A$9.98flatN/AN/A$215.17MN/A0.00N/AHigh Trading VolumeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180ZYMEZymeworks1.8325 of 5 stars$14.36+0.4%$21.43+49.2%+29.6%$1.08B$122.87M-9.57460SBTXSilverback TherapeuticsN/A$14.53+0.4%N/A+9.0%$523.92MN/A-6.0083Positive NewsHigh Trading VolumeMBXMBX Biosciences2.6152 of 5 stars$14.72+11.4%$37.63+155.6%N/A$443.78MN/A-3.2436AVTEAerovate TherapeuticsN/A$7.36+8.7%N/A-88.8%$213.33MN/A-2.4620Gap UpHigh Trading VolumeNLTXNeoleukin TherapeuticsN/A$20.51+1.5%N/A-45.0%$192.75MN/A-6.5990High Trading VolumeCYBNCybin2.5036 of 5 stars$7.06-1.5%$85.00+1,104.0%N/A$169.14MN/A-1.6150News CoveragePositive NewsAnalyst RevisionBIOABioAge LabsN/A$4.55+2.0%N/AN/A$159.89M$3.86M0.00N/AHigh Trading VolumeVIRIVirios TherapeuticsN/A$4.93+0.2%$5.00+1.4%+2,052.3%$94.94MN/A-18.265WHWKWhitehawk TherapeuticsN/A$1.60-1.2%N/AN/A$76.35M$25.98M-26.6740High Trading Volume Related Companies and Tools Related Companies CALT Competitors ZYME Competitors SBTX Competitors MBX Competitors AVTE Competitors NLTX Competitors CYBN Competitors BIOA Competitors VIRI Competitors WHWK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LWAC) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LightWave Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share LightWave Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access